Volver a Publicaciones 2003 >> HISTÓRICO PUBLICACIONES

PUBLICACIONES 2001
Ver: Hasta 1989 | 1990-94 | 1995-99 | 2000 | 2001 | 2002 | 2003
 

  • Rodriguez-Campos A, Ruiz-Enriquez P, Badimon L.
    Vascular smooth muscle cell p53 is lost before entering migration and proliferation.
    Arteriosclerosis, Thrombosis and Vascular Biolgy 21: 214-219; 2001

  • Martínez-González J, Llorente-Cortés V, Badimon L.
    Cellular and molecular biology of atherosclerotic lesions.
    Revista Espanola de Cardiologia 54: 218-231;2001

  • Rodriguez-Sinovas C, Martínez-González J, Sánchez-Gómez S, Badimon L.
    LDL downregulate CYP51 in vascular endothelial cells and in the arterial wall through a REBP-2 dependent mechanism
    Circulation Research 88: 268-274; 2001

  • Pedreno J, Hurt-Camejo E, Wiklund O, Badimon L, Masana L.
    Low-density lipoprotein (LDL) binds to a G-protein coupled receptor in human platelets. Evidence that the proaggregatory effect induced by LDL is modulated by down-regulation of binding sites and desensitization of its mediated signaling.
    Atherosclerosis 155: 99-112; 2001

  • Martínez-González J, Raposo B, Rodríguez C, Badimon L.
    3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of native LDLs. Balance between transcriptional and post-transcriptional regulation.
    Arteriosclerosis, Thrombosis and Vascular Biolgy 21: 804-809; 2001

  • Badimon L.
    Atherosclerosis and thrombosis. Lessons from animal models.
    Thrombosis and Haemostasis 86: 356-365; 2001

  • Badimon L.
    New challenges in the etiopathogenesis of atherothrombosis.
    Cerebrovascular Diseases 11 : 80-84; 2001

  • Alonso R, Mata P, de Andres R, Villacastín BP, Martínez-González J, BadimonL
    Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin
    Atherosclerosis 157 : 423-429; 2001

  • Badimon L, Vilahur G, Sánchez S, Duran X.
    Atheromatous plaque formation and thrombogenesis : formation, risk factors and therapeutic approaches.
    Eur Heart J Supplements 3 (suppl I):I16-I22; 2001

  • Martínez-González J, Alfón J, Berrozpe M, Badimon L.
    HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels.
    Atherosclerosis 159 ; 27-33; 2001

  • Badimon L.
    Fisiopatología de los síndromes coronarios agudos. Papel de la rotura de la placa arteriosclerótica.
    Revista Española de Cardiologia 1 (Supl. B) : 2B-13B; 2001
  • Martínez-González J, Berrozpe M, Varela O, Badimon L.
    Heterogeneity of smooth muscle cells in advanced human atherosclerotic plaques : intimal smooth muscle cells expressing a fibroblast surface protein are highly ativated by platelet-released products.
    European Journal of Clinical Investigation 31 : 939-949; 2001)
  • Martinez-Gonzalez J, Berrozpe M, Badimon L
    Historia natural de la arteriosclerosis. Manifestaciones clinicas. Complicaciones agudas y crónicas. Valoración diagnóstica.
    Medicine, 8 (42): 2230-2239; 2001

  • Cia P, Armario P, Badimon L, Redón J. SEA, SELELHA
    Hipertensión arterial en el paciente dislipémico.
    Clínica e Investigación en Arterioclerosis 13 (5) : 179-194; 2001

  • Llorente-Cortés V, Otero-Vinas M, Martínez-González J, Badimon L.
    Differential involvement of extracellular matrix on the low density lipoprotein receptor-related protein mediated aggregated LDL uptake in human vascular smooth muscle cells and mouse embryonic fibroblasts.
    European Journal for Clinical Investigation, 31: (#102) 24; 2001

  • Rius J, Martinez-González J, Crespo-Asensio J, Badimon L.
    LDL activate NOR-1 expression by a PKA, PKC and CREB dependent mechanism in human vascular smooth mucle cells.
    European Journal for Clinical Investigation, 31: (#101) 23; 2001

  • Rodriguez C, Raposo B, Martínez-González J, Badimon L.
    Atherogenic levels of LDL downregulate lysyl oxidase mRNA in endothelial cells.
    European Journal for Clinical Investigation, 31: (#100) 23; 2001

  • Escudero I, Martínez-González J, Badimon L.
    Lipoprotein fatty acid composition regulates their effect on smooth muscle cell prostacyclin production.
    European Journal for Clinical Investigation, 31: (#97) 22; 2001

  • Escudero I, Martínez-González J, Badimon L.
    Lipoproteins induce prostacyclin release in human aortic smooth muscle cells through a cyclo-oxygenase 2 upregulation dependent on pertussis toxin-sensitive G proteins and p42 MAPK.
    European Journal for Clinical Investigation, 31: (#96) 22; 2001

  • Casani L, Escudero I, Badimon L.
    Analysis of the PGI2 released by pig aortic smooth muscle cells induced with lipoproteins from pigs subjected to different diets.
    European Journal for Clinical Investigation, 31: (#95) 22; 2001

  • Royo T, Casaroli R, Badimon L.
    Absence of the vWF secretory pathway inporcine arterial endothelial cells.
    European Journal for Clinical Investigation, 31: (#20) 5; 2001

  • Raposo B, Rodriguez C, Llorente-Cortés V, Martínez-González J, Badimon L.
    Las LDL regulan la expresion de esterol metil oxidasa (ERG25) en células vasculares.
    Clínica e Investigación en Arteriosclerosis 13: 13 ; 2001

  • Rodriguez C, Martinez-González J, Raposo B, Badimon L.
    Las lipoproteinas nativas de baja densidad potencian la apoptosis inducida por privacion de suero en células endoteliales.
    Clínica e Investigación en Arteriosclerosis 13: 13 ; 2001

  • Crespo-Asensio J, Martínez-González J, Rius J, Badimon L.
    La composición lipidica de las lipoproteinas modula la induccion temprana de NOR-1 en células musculares lisas de coronaria humana.
    Clínica e Investigación en Arteriosclerosis 13: 16 ; 2001

  • Otero-Vinas M, Llorente-Cortés V, Casaní L, Berrozpe M, Badimon L.
    La expresión del receptor "low density lipoprotein receptor-related protein" estaaumentada en la pared vascular de cerdos hipercolesterolemicos frente a los normocolesterolemicos.
    Clínica e Investigación en Arteriosclerosis 13: 20 ; 2001

  • Vilahur G, Duran X, Rodriguez-Campos A, Badimon L.
    Regulacion de p53 en pared vascular sana y aterosclerotica
    Clínica e Investigación en Arteriosclerosis 13: 24 ; 2001

  • Sánchez-Gómez S, Casani L, Vilahur G, Badimon L.
    FFR-rFVIIa inhibits thrombosis triggered by ruptured and eroded vessel wall.
    Thrombosis and Haemostasis, July : # OC999; 2001

  • Casani L, Sánchez-Gómez S, Vilahur G, Ruiz N, Segalés E, Badimon L.
    Olive oil attenuates thrombosis triggered by arterial wall injury at different shear conditions in the porcine model.
    Thrombosis and Haemostasis, July : # P1615; 2001

  • Vilahur G, Sánchez-Gómez S, Casani L, Badimon L.
    Dietary olive oil intake reduces platelet depostion on human atherosclerotic vessel wall. In vitro perfusion study.
    Thrombosis and Haemostasis, July : # P494; 2001

  • Sánchez-Gómez S, Casaní L, Badimon L.
    Preventive effects of statins on thrombotic risk are not solely attributable to plasma cholesterol levels reduction.
    European Heart Journal, 22 : 452 (#P2379); 2001

  • Badimon L, Vilahur G.
    Inflamación y arteriosclerosis
    XIV Jornades Catalanes sobre Hipertensió Arterial, 13; 2001